MedKoo Cat#: 126664 | Name: SI-12

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SI-12 is a SRC3 inhibitor (MCF7: IC50 = 3.4 nM) with improved pharmacokinetic properties and anticancer efficacy.

Chemical Structure

SI-12
SI-12
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 126664

Name: SI-12

CAS#: N/A

Chemical Formula: C15H12F3N5

Exact Mass: 319.1045

Molecular Weight: 319.29

Elemental Analysis: C, 56.43; H, 3.79; F, 17.85; N, 21.93

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
SI-12; SI12; SI 12
IUPAC/Chemical Name
(E)-5,6-difluoro-2-(((E)-1-(5-fluoropyridin-2-yl)ethylidene)hydrazineylidene)-1-methyl-2,3-dihydro-1H-benzo[d]imidazole
InChi Key
QPBNFTTUAKVEKN-ODCIPOBUSA-N
InChi Code
InChI=1S/C15H12F3N5/c1-8(12-4-3-9(16)7-19-12)21-22-15-20-13-5-10(17)11(18)6-14(13)23(15)2/h3-7H,1-2H3,(H,20,22)/b21-8+
SMILES Code
FC1=C(F)C=C(N/2[H])C(N(C)C2=N\N=C(C)\C3=NC=C(F)C=C3)=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 319.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Qin L, Chen J, Lu D, Jain P, Yu Y, Cardenas D, Peng X, Yu X, Xu J, Wang J, O'Malley BW, Lonard DM. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocr Relat Cancer. 2021 Aug 13;28(10):657-670. doi: 10.1530/ERC-20-0402. PMID: 34310341; PMCID: PMC8404148. 2: Bijou I, Liu Y, Lu D, Chen J, Sloan S, Alinari L, Lonard DM, O'Malley BW, Wang M, Wang J. Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma. Res Sq [Preprint]. 2023 Mar 10:rs.3.rs-2653461. doi: 10.21203/rs.3.rs-2653461/v1. PMID: 36945511; PMCID: PMC10029087. 3: Lu D, Chen J, Qin L, Bijou I, Yi P, Li F, Song X, MacKenzie KR, Yu X, Yang B, Roy Chowdhury S, Korp JD, O'Malley BW, Lonard DM, Wang J. Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. J Med Chem. 2024 Mar 29. doi: 10.1021/acs.jmedchem.3c01596. Epub ahead of print. PMID: 38551814.